Free Trial

Herbalife (NYSE:HLF) Trading Up 9.5% - Should You Buy?

Herbalife logo with Retail/Wholesale background
Remove Ads

Herbalife Ltd. (NYSE:HLF - Get Free Report)'s stock price was up 9.5% on Tuesday . The stock traded as high as $6.30 and last traded at $6.16. Approximately 931,513 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 1,928,353 shares. The stock had previously closed at $5.62.

Analyst Ratings Changes

Several analysts have weighed in on HLF shares. Citigroup lowered their price target on Herbalife from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Friday, October 25th. B. Riley lowered their price target on Herbalife from $17.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday, October 31st. DA Davidson reaffirmed a "neutral" rating and issued a $7.50 price target on shares of Herbalife in a report on Thursday. Mizuho raised their price target on Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a report on Friday, November 1st. Finally, StockNews.com raised Herbalife from a "hold" rating to a "buy" rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, Herbalife currently has an average rating of "Hold" and an average price target of $9.90.

Check Out Our Latest Analysis on HLF

Remove Ads

Herbalife Trading Up 3.1 %

The company has a market capitalization of $836.72 million, a PE ratio of 3.32, a PEG ratio of 0.29 and a beta of 1.15. The stock has a fifty day moving average of $6.27 and a two-hundred day moving average of $7.24.

Herbalife (NYSE:HLF - Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.08 by $0.28. The company had revenue of $1.21 billion for the quarter, compared to analysts' expectations of $1.19 billion. Herbalife had a negative return on equity of 20.78% and a net margin of 5.09%. Equities analysts forecast that Herbalife Ltd. will post 1.57 EPS for the current year.

Hedge Funds Weigh In On Herbalife

A number of large investors have recently bought and sold shares of HLF. Diversify Wealth Management LLC increased its stake in Herbalife by 271.4% in the 3rd quarter. Diversify Wealth Management LLC now owns 159,499 shares of the company's stock worth $1,113,000 after purchasing an additional 116,548 shares during the period. Iridian Asset Management LLC CT increased its stake in Herbalife by 43.7% in the 3rd quarter. Iridian Asset Management LLC CT now owns 2,228,193 shares of the company's stock worth $16,021,000 after purchasing an additional 677,739 shares during the period. Harbor Capital Advisors Inc. increased its stake in Herbalife by 139.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 38,020 shares of the company's stock worth $273,000 after purchasing an additional 22,138 shares during the period. Prospera Financial Services Inc bought a new stake in shares of Herbalife in the 3rd quarter worth approximately $154,000. Finally, Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Herbalife by 31.1% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 550,795 shares of the company's stock worth $3,960,000 after buying an additional 130,818 shares during the last quarter.

About Herbalife

(Get Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Read More

Should You Invest $1,000 in Herbalife Right Now?

Before you consider Herbalife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.

While Herbalife currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads